Lyme borreliosis: Laboratory considerations

Seminars in Neurology

Volumn 17, Issue 1, 1997, Pages 11-17

  Golightly, Marc G ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

cellular response; ELISA; PCR; Predictive value; Western Blot

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BACTERIUM IDENTIFICATION; BORRELIA BURGDORFERI; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; LYME DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY;

EID: 0030912595     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040907     Document Type: Article

References (65)

1. Golightly MG. Laboratory consideration in the diagnosis and management of Lyme borreliosis. AJCP 1993;99:168-74
2. Kaell AT, Volkman DJ, Gorevic PD, Dattwyler RJ. Positive Lyme serology in subacute bacterial endocarditis. JAMA 1990;264: 2916-18
3. Magnarelli LA, Anderson JF. Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi. Am J Epidemiol 1988;127:818-25
4. Ley C, Le C, Olshen EM, Reingold AL. The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA 1994;271:460-3
5. Ransohoff DF, Feinstein AR Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299:926-30
6. Benach JL, Bosler EM, Hanrahan JP, Coleman JL, Habicht GS, Bast TF, Cameron DJ, Ziegler JL, Barbour AG, Burgdorfer W, Edelman R, Kaslow RA. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983;308:740-2
7. Berger BW, Johnson RC, Kodner C, Coleman L Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992;32:359-61
8. Johnson RC, Hyde FW, Schmid GP, Brenner DJ. Borrelia burgdorferi sp. nov.: Etiologic agent of Lyme disease. Int J Syst Bacteriol 1984;34:496-7
9. Steere AC, Grodzicki AN, Kornblatt JE, Craft JE, Barbour AG, Schmid GP, Johnson E, Malawista SE. The spirochetal etiology of Lyme disaese. N Engl J Med 1983;30:733-40
10. NIH State of the Art Conference, Diagnosis and Treatment of Lyme Disease. Clinical Courier 1991;9:1-8
11. Nadelman RB, Pavia CS. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 1990;88:21-6
12. Shwartz I, Wormser GP, Schwartz JJ, Cooper D, Weissensee P, Gazumyan A, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions J Clin Microbio 1992; 30 3082-8
13. Schwartz I, Bittker S, Bowen SL, Cooper D, Pavia C, Wormser GP. Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 1993;12:879-82
14. Quan TJ, Wilmoth BA, Carter LG, Bailey RE. A comparison of some commercially available serodiagnostic kits for Lyme disease. In: Proceedings of the First National Conference on Lyme Disease Testing. Washington, DC: ASTPHLD Headquarters; 1991:61-73
15. Benach JL, Coleman JL, Golightly MG. A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete. J Immunol 1988;140:265-72
16. Boiser EM, Schulze T The prevalence and significance of Borrelia burgdorferi in the urine of feral reservoir hosts. Zbl Bakteriol Hyg A 1986;263:40-4
17. Rosa PA, Schwan TG. A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis 1989;160:1018-29
18. Bradley JF, Johnson RC, Goodman JL. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 1994;120:487-9
19. Sigal LH. The polymerase chain reaction assay for Borrelia burgdorferi in the diagnosis of Lyme disease. Ann Intern Med 1994;120:520-1
20. Goodman JL, Jurkovich D, Kramber JM, Johnson RC. Molecular persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun 1991;59:269-78
21. Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992;42:32-42
22. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis N Engl J Med 1994;330:229-34
23. Goodman JL, Bradley JF, Ross AE, Goellner P, Lagus A, Vitale B, Berger BW, Luger S, Johnson RC Bloodstream invasion in early Lyme disease: Results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 1995;99(1):6-12
24. Golightly MG, Soirez L, Viciana A. Variability in Lyme borreliosis testing among commercial diagnostic kits. IV International Conference on Lyme Borreliosis, Stockholm, 1990
25. Golightly MG, Thomas JA, Viciana AL. The laboratory diagnosis of Lyme borreliosis. Lab Med 1990;21:299-304
26. Luger S, Krauss E. Serologic tests for Lyme disease: Interlaboratory variability. Arch Intern Med 1990;150:761-3
27. Magnarelli LA. Quality of Lyme disease tests. J Am Med Assoc 1989;262:3464-5
28. Craft JE, Grodzicki RL, Steere AC. Antibody response in Lyme disease. Evaluation of diagnostic tests. J Infect Dis 1984; 149:795-799
29. Golightly MG, Vicianna A. False positives in ELISA and Western blots. In Schutzer S, ed Lyme disease: Molecular and immunological approaches Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1992
30. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984;149: 465-70
31. Muhlemann M, Wright D, Black C. Serology of Lyme disease. Lancet 1986;1:553-4
32. Magnarelli LA, Anderson JF, Johnson RC. Cross reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis 1987;156:183-8
33. Magnarelli LA, Meegan JM, Anderson JF. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies in Lyme disease. J Clin Microbiol 1984;20:11-4
34. New York State Department of Health Proficiency Tests 1990, 1991, 1992, 1993
35. Gill JS, Johnson RC. Immunologic methods for the diagnosis of infections by Borrelia burgdorferi (Lyme disease). In Rose, de Macario, Fahey, Friedman, Penn, eds. Manual of clinical laboratory immunology. Washington, DC: ASM Press, 1992
36. Fister RD, Weymouth LA, McLaughlin JC, Ryan RW, Tilton RC. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol 1989;27:234-7
37. Golightly MG, Thomas JA. Enzyme immunoassay for antibodies to Borrelia burgdorferi. In Isenberg HD, ed. Clinical microbiology procedures handbook. Washington, DC: ASM Press, 1993: 9.8.1-9.8.8.
38. Grodzicki RL, Steere AC. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis 1988;157(4):790-7
39. Hansen K, Hindersson P, Strandberg Pedersen N. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988;26:338-46
40. Simpson WJ, Schrumpf ME, Schwan TG. Reactivity of human Lyme Borreliosis sera with a 39 kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol 1990;28:1329-37
41. WSLH/CAP Lyme disease surveys, 1993
42. Public Law No. 100-578, 100th Cong. (31 October 1988), 102 Stat. 2903, "Clinical Laboratory Improvement Amendments of 1988".
43. Coleman JL, Benach JL. Isolation of antigenic components from the Lyme disease spirochete: Their role in early diagnosis. J Infect Dis 1987;155:756-65
44. Barbour AG, Burgdorfer W, Grunwaldt E, Steere AC. Antibodies of patients with Lyme disease to components of Ixodes dammini spirochete. J Clin Invest 1983;72:504-15
45. Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Borrelia burgdorferi recognized during Lyme disease Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 1986;78:934-9
46. Bergstrom S, Sjostedt A, Dotevall L, Kaijser B, Ekstrand-Hammarstrom B, Wallberg C, Skogman G, Barbour AG. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components. Eur J Clin Microbiol Infect Dis 1991;10(5): 422-7
47. Magnarelli LA, Fikrig E, Berland R, Anderson JF, Flavell RA. Comparison of whole cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol 1992;30(12):3158-62
48. Raoult D, Hechemy K, Baranton G. Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis. J Clin Microbiol 1989;27:2152-5
49. Steere AC, Grodzicki AN, Kornblatt JE, Craft JE, Barbour AG, Schmidt GP, Johnson E, Malawista SE. The spirochetal etiology of Lyme disease. N Engl J Med 1983;30:733-40
50. Levinson S, Denys G. Strengths and weaknesses in methods for identifying the causative agent(s) of acquired immunodeficiency syndrome (AIDS). CRC Crit Rev Clin Lab Sci 1988; 26:277-300
51. CDC. Recommendations for test performance and interpretation from the Second National Conference on the serologic diagnosis of Lyme disease. MMWR 1995;44(31):590-1
52. Dressler F, Whalen J, Reinhardt B, Steere A. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167: 392-400
53. Karlsson MK, Mollegard I, Stiernstedt G, Wretlind B. Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis. Eur J Clin Microbiol 1989; 8:871-7
54. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-22
55. Cook WD, Bartenhagen NH. Seroreactivity to Borrelia burgdorferi antigens in the absence of Lyme disease. J Rheum 1994; 21(1):126-31
56. Krzysztof K, Weinstein A. Western blot band intensity analysis: Application to the diagnosis of Lyme arthritis. Arth Rheum 1994;37:1206-11
57. Dattwyler RJ, Volkman DJ, Luft BJ, Halprin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1989;319:1441-6
58. Dressler F, Yoshinari M, Steere A. The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med 1991;115: 533-9
59. Oppenheim J, Schecter B. Lymphocyte transformation. In Rose N, Friedman H, eds. Manual of clinical immunology. Washington, DC: American Society for Microbiology, 1976:81-91
60. Zoschke D, Skemp A, Defosse D. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann Intern Med 1991; 114:285-9
61. CDC. Ceftriaxone-associated biliary complications of treatment of suspected disseminated Lyme disease - New Jersey. MMWR 1993;42(2):39-42
62. Luft BJ, Gardner P, Lightfoot RW, Jr, et al. Empiric antibiotic treatment of patients who are seropositive but lack classic features. Clin Infect Disect 1994;18:112
63. Barbour AG. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev 1988;1(4):399-414
64. Lavoie PE, Lane RS, Murray RH Seronegative Lyme borreliosis in three Californians with late manifestations. Arthritis Rheum 1987;30(4):S36
65. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990;335:312-5